Hello Everyone,
I would like to provide update and seek advice since I got a Prostate MRI at Johns Hopkins a week ago. I have included links to my past post for reference:
healthunlocked.com/prostate......
healthunlocked.com/prostate...
Here is the MRI results. I have a transperineal MRI scheduled at Johns Hopkins later this month. This will be about 8 months after my initial TRUS biopsy.
What does the "HEMORRHAGE" section mean?
Any feedback and advice will be apprecaited.
MRI PROSTATE
Results
Impression
IMPRESSION:
1. No MRI evidence of suspicious focal lesion.
2. Mild BPH.
Overall PI-RADS = 2/5
Overall Assessment Categories (PI-RADS V2.1):
Likelihood that a clinically significant cancer is present based on MRI parameters
1. Very low (clinically significant cancer is highly unlikely to be present)
2. Low (clinically significant cancer is unlikely to be present)
3. Intermediate (the presence of clinically significant cancer is equivocal)
4. High (clinically significant cancer is likely to be present)
5. Very high (clinically significant cancer is highly likely to be present)
Baseline Study.
Images and interpretation personally reviewed by: Paniz Charkhchi, MD
Images and interpretation personally reviewed by: ATIF ZAHEER, MD
Narrative
EXAM: MRI PROSTATE W/WO CONTRAST WITH 3D
TECHNIQUE:
Imaging at 3 Tesla performed at Johns Hopkins.
Coil: Body Matrix coil
Sequences: Small field of view imaging of the prostate was performed with axial and coronal T2 weighted imaging, diffusion weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping. Axial T1 weighted imaging pre-contrast and dynamic contrast enhanced (DCE) imaging was performed following injection of 0.1 mmol/kg gadolinium IV. Large field of view images of the pelvis were obtained axial T1 weighted with fat suppression after contrast administration. Offline post-processing of DCE data was performed on a dedicated Invivo DynaCAD workstation to generate pharmacokinetic maps.
Post-processing: Additional post-processing of MRI data was performed on a separate DynaCAD workstation, to include volumetric segmentation of the prostate (DCAD Prostate Boundary).
FINDINGS:
HEMORRHAGE:
Increased T1 signal consistent with hemorrhage, limiting the evaluation.
PROSTATE VOLUME:
Prostate measures: 5.1 cm TV x 3.5 cm AP x 5.7 cm CC, volume 53 cc.
Prostate volume calculated in DynaCAD Prostate Boundary segmentation: 50 cc
PERIPHERAL ZONE:
Symmetric high signal on T2-weighted imaging with no restricted diffusion or asymmetric perfusion. Few linear areas of low signal likely representing scarring.
TRANSITION ZONE:
Mild hypertrophy with heterogeneous T2-signal.
SEMINAL VESICLES: Normal, symmetric.
NEUROVASCULAR BUNDLES: Normal, symmetric.
BLADDER NECK: Normal
MEMBRANOUS URETHRA: Normal
LYMPH NODES: None enlarged.
BONE MARROW: Normal signal intensity.